Evozyne
Biotechnology ResearchIllinois, United States51-200 Employees
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs.
Insights
Leadership Change Evozyne's recent appointment of Marc Yoskowitz as CEO presents an opportune moment for sales outreach, as new leadership often brings fresh initiatives and partnerships that may open up new business opportunities.
AI Development The collaboration with NVIDIA to develop AI models for designing therapeutic proteins showcases Evozyne's innovative approach. Positioning your offerings as complementary to their AI technology could lead to mutually beneficial partnerships.
Funding Growth Having raised substantial funds in Series B financing, Evozyne is likely in a phase of expansion and investment. This presents a chance for sales engagements, offering solutions that align with their growth plans and strategic objectives.
Protein Therapeutics Focus Evozyne's core focus on designing novel protein therapeutics indicates a specialized niche within the biotech industry. Tailoring your sales pitch to highlight how your products or services can enhance their therapeutic protein development could resonate well.
Sustainability Aspect With Evozyne's emphasis on developing high-performing novel proteins, there may be an opportunity for sales professionals in sustainability-focused companies to highlight how their eco-friendly solutions can contribute to Evozyne's mission and sustainable practices.
Similar companies to Evozyne
Carlsmed
86
$10M$50MC16 Biosciences
36$10MNotch Therapeutics
70$10M$50MInsilico Medicine
292$50M$100MLygos
85$10M$50MProteinQure
26$10MAbsci
184$10M$50MGRO Biosciences
33$10MArzeda
67$10M
Evozyne Tech Stack
Evozyne uses 8 technology products and services including GitHub, NoSQL, MySQL, and more. Explore Evozyne's tech stack below.
- GitHubCommunication And Collaboration
- NoSQLDatabase
- MySQLDatabase
- AsanaIssue Trackers
- ReactJavascript Frameworks
- JavaScriptProgramming Languages
- HaskellProgramming Languages
- LinuxProgramming Languages
Media & News
Evozyne's Email Address Formats
Evozyne uses at least 1 format(s):
| Evozyne Email Formats | Percentage |
| First.Last@evozyne.com | 50% |
| First.Last@evozyne.com | 50% |
Frequently Asked Questions
Where is Evozyne's headquarters located?
Evozyne's main headquarters is located at Chicago, IL US. The company has employees across 3 continents, including North AmericaAsiaEurope. What is Evozyne's official website and social media links?
Evozyne's official website is evozyne.com and has social profiles on LinkedIn.How much revenue does Evozyne generate?
As of October 2024, Evozyne's annual revenue reached $15M. What is Evozyne's SIC code NAICS code?
Evozyne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Evozyne have currently?
As of October 2024, Evozyne has approximately 59 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: M. Y.Chief Drug Discovery Officer: U. H.Chief Operating Officer: A. R.. Explore Evozyne's employee directory with LeadIQ.What industry does Evozyne belong to?
Evozyne operates in the Biotechnology Research industry. What technology does Evozyne use?
Evozyne's tech stack includes GitHubNoSQLMySQLAsanaReactJavaScriptHaskellLinux. What is Evozyne's email format?
Evozyne's email format typically follows the pattern of . Find more Evozyne email formats with LeadIQ. How much funding has Evozyne raised to date?
As of October 2024, Evozyne has raised $81M in funding. The last funding round occurred on Sep 27, 2023 for $81M.When was Evozyne founded?
Evozyne was founded in 2020.
Company Overview
- Headquarters
- Chicago, IL US
- Website
- evozyne.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2020
- Employees
- 51-200
Media & News
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $10M$50M
Evozyne's revenue is in the range of $10M$50M
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $10M$50M
Evozyne's revenue is in the range of $10M$50M
Company Leadership
M. Y.Chief Executive Officer- U. H.Chief Drug Discovery Officer
- A. R.Chief Operating Officer
J. A.Vice President Operations- A. F.Head Of Computation
Employee Directory
D. P.Executive Assistant To The Chief Executive Officer- R. R.Co-Founder, Chief Scientist
- S. B.Executive Assistant To Cofounder And Chief Scientific Officer
- J. A.Vice President Operations
- B. R.Vp, Protein Engineering
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
